HerWellReport Independent Women’s Health Research

Bladder & Pelvic Health

Why Do I Leak When I Sneeze, Laugh or Cough?

Two women in their fifties talking and laughing across a sunlit kitchen table

HerWellReport is reader-supported. We may earn a commission from links on this page at no extra cost to you — see our affiliate disclosure. This article is information, not medical advice; please read our medical disclaimer.

You sneeze, and you leak. Or you laugh at something on the phone, or lift a bag of compost, or land badly in a tennis rally, and there it is again. Nobody warned you about this, and the internet’s answer — “do your Kegels” — has not worked, because nobody told you what a real programme looks like.

This is stress urinary incontinence: leaking when something raises the pressure inside your abdomen. It is not a weak bladder, and it is not a sign that your bladder has stopped working. It is a mechanical failure of the support underneath your urethra. That distinction matters, because it tells you which treatments can possibly help and which cannot.

What is actually happening when you leak

Stress incontinence is defined as the sudden involuntary loss of urine during activities that raise pressure inside the abdomen — laughing, sneezing, coughing, exercising.1 There are two underlying mechanisms, and they are not the same problem.

The commoner one in women is urethral hypermobility. The urethra sits on a supportive layer — the levator ani muscles, the front wall of the vagina, the pelvic fascia and the pubourethral ligaments, working together as a kind of hammock, with a fascial arch acting as the cable it hangs from.2 When pressure spikes, the fast-twitch fibres of the levator contract quickly and the urethra is squashed shut against that backstop. If the support has been stretched or torn, the urethra rotates downwards instead of being pinned, and urine escapes.1

The second mechanism is intrinsic sphincter deficiency — the closing muscle of the urethra itself is not doing its job, often after neuromuscular changes or previous pelvic surgery. It tends to produce heavier leaking.1

Oestrogen has a part in this, but a smaller and more specific one than most articles imply. It acts on the network of small blood vessels just under the lining of the urethra, keeping that lining plump enough to form a watertight seal.2 When oestrogen falls, that seal is less effective. But topical oestrogen does not directly restore urethral continence, and the evidence for it in stress incontinence specifically is described as equivocal.1 If you want the fuller picture of what oestrogen loss does to the whole area, we cover it in perimenopause and your bladder.

A useful way to hold it in your head: the sphincter is the tap, and the hammock is the shelf it closes against. A capsule you swallow reaches neither.

Why now, when the children were born twenty years ago?

This is the question we hear most, and the answer is that birth supplies the structural injury while ageing supplies the moment it stops being compensated for.

The obstetric effect is still measurable decades later. In a large longitudinal cohort of women aged 42 to 52 at entry, having given birth roughly doubled the odds of urinary incontinence compared with women who had not — odds ratio 1.85 for one birth and 1.93 for more than one — and among women who had given birth more than once, vaginal delivery carried about twice the odds of caesarean.3

Meanwhile the reserve that hid the problem runs down. Muscle function, the fast-twitch fibres of the sphincter and the oestrogen-dependent urethral seal all decline with age.12 A support system that coped at 32 stops coping at 52.

And here is the correction to the “it’s just the menopause” story: a 2025 review of incontinence in menopause found no evidence of a specific jump in prevalence at the onset of menopause. Prevalence rises in a broadly linear way with age instead.4 Menopause is part of the picture — it is not the switch. We go through the whole timeline in what happened in your thirties and bladder changes by decade.

What raises the risk

  • Pregnancy and vaginal birth — the strongest and best-quantified factor.35
  • Age — prevalence climbs steadily rather than jumping.4
  • Body weight — NICE advises weight loss for women with a BMI above 30, and European guidance makes losing and maintaining weight a strong recommendation.67
  • Chronic cough, smoking, chronic constipation, heavy lifting, previous pelvic surgery including hysterectomy — all listed as modifiable contributors.1 Worth knowing: one large retrospective study did not find chronic cough and constipation to be independent risks once other factors were accounted for, so treat them as plausible mechanical contributors rather than settled causes.
  • Family history — the NHS lists it among risk factors, and researchers suspect inherited differences in connective tissue play a part.5
  • Prolapse and pelvic trauma — named among causes by the US National Institute of Diabetes and Digestive and Kidney Diseases.8

How common is it, really?

You will see confident statistics everywhere. We are not going to give you one, and the reason is instructive. The American Urological Association’s own guideline says the prevalence of stress incontinence “has been reported to be as high as 49%, depending on population and definition.”9 That last clause is the whole story: a woman who leaks once a year and a woman who leaks every day both answer yes on most surveys.

Published estimates run from roughly one in seven women in some European samples to nearly half in others, with the variation attributed to under-reporting, different age groups, different measurement methods and geographic differences.1 A review focused on menopause puts urinary incontinence at 45 to 50% of menopausal women.4 The only figure that helps you is your own: how often, how much, and how much it is costing you. A short symptom check is a better starting point than a statistic.

What actually works, in order of evidence

1. Supervised pelvic floor muscle training — the one with the best evidence

A Cochrane review found that among women with stress incontinence, those doing pelvic floor muscle training were around eight times more likely to report being cured — 56% versus 6% — on high-quality evidence, and six times more likely to report cure or improvement, 74% versus 11%. Leakage fell by roughly one episode per 24 hours, quality of life improved, and side effects were rare and minor.10

Those are trial results from a proper programme, not from squeezing occasionally at traffic lights. Here is the programme the guidelines actually specify, which is the part almost every article leaves out:

  • NICE: offer a trial of supervised pelvic floor muscle training of at least three months as first-line treatment for stress or mixed incontinence.6
  • Programmes should comprise at least 8 contractions performed 3 times a day.6
  • Before that programme starts, a clinician should confirm by digital examination that you can actually contract the muscle.6 A meaningful number of women squeeze the wrong thing entirely, which is precisely why “supervised” is in the recommendation.
  • European guidance is equally direct: offer supervised intensive training lasting at least three months as first-line therapy to all women with stress incontinence — a strong recommendation.7

If you have been doing them alone for a fortnight and nothing has changed, the problem is almost certainly the programme, not you. And if you have already tried and got nowhere, we wrote a whole piece on why Kegels are not working.

2. Weight loss, where weight is a factor

NICE advises weight loss above a BMI of 30, and the European Association of Urology makes it a strong recommendation.67 The clinical summary literature reports that a weight reduction of around 8% achieved through exercise was followed by close to a 50% fall in incontinence episodes.1 That is a modest, achievable loss — not a demand to become thin.

3. Pessaries and vaginal inserts — genuinely useful for some, and the guidelines disagree

The American guideline says clinicians may offer a continence pessary or vaginal insert, and that counselling before surgery must include them.9 Reported symptom improvement is around a third of patients.1 Cochrane, reviewing 8 trials in 787 women, concluded that mechanical devices might be better than no treatment but the evidence is weak and their place “remains in question.”11 NICE goes further and says do not use intravaginal or intraurethral devices for routine management.6

We are flagging the disagreement rather than picking a side. In practice these are most often considered by women who leak mainly during a specific activity, such as running.

4. Vaginal oestrogen — real, but for a different job

Cochrane found local oestrogen may improve incontinence overall, with a risk ratio of 0.74 and roughly one to two fewer trips to the loo in 24 hours, with minor side effects.12 But European guidance records that local oestrogen was less likely to improve incontinence than pelvic floor muscle training,7 and the clinical literature describes the evidence in stress incontinence specifically as equivocal, because topical oestrogen does not directly affect urethral continence.1

Systemic HRT is the opposite of a fix here. Pooled trials found incontinence was worse than placebo with systemic oestrogen — risk ratio 1.32 — and women who were continent to begin with were more likely to develop incontinence on it.12 NICE says plainly: do not offer systemic hormone replacement therapy to treat urinary incontinence.6 That is a different question from whether HRT is right for you overall, which we look at in does HRT help bladder problems.

5. Duloxetine — modest benefit, real cost

Cochrane, across 10 trials and 3,944 adults, found duloxetine reduced leak frequency and improved quality of life, but the pad-test analysis did not show a benefit over placebo and the advantage on subjective cure was small. About one in three women reported side effects, most often nausea, and about one in eight stopped because of them. Trials ran only 3 to 12 weeks, so long-term durability is unknown.13 NICE’s position: do not use it first-line, and do not routinely offer it second-line.6

6. Surgery — effective, and a genuine decision

The American guideline gives counselling on midurethral slings a strong recommendation at the highest evidence grade, with retropubic, transobturator and single-incision approaches all available.9 NICE says that after non-surgical management has failed, women should be offered a choice of colposuspension, an autologous rectus fascial sling, or a retropubic mid-urethral mesh sling, using a decision aid and with an explicit discussion of the uncertainties about long-term effects, particularly for implanted mesh. Bulking agents are reserved for when those are unsuitable and are less effective.6 Reported overall surgical cure rates sit around 84%.1

Note the two guidelines diverge again: NICE restricts the transobturator route to specific circumstances, the American guideline lists it as an option.69

7. Supplements — where they honestly sit

No dietary supplement appears among the recommended treatments in NICE’s guideline, the American Urological Association’s stress incontinence guideline, or European guidance.697 NICE goes further and states directly: do not recommend complementary therapies for the treatment of urinary incontinence or overactive bladder.6

The mechanism argument points the same way. Nothing you swallow rebuilds urethral support or retrains the levator ani. Be especially wary of pages that put cranberry or probiotics in front of a leaking problem — the cranberry evidence base, 50 trials and 8,857 people in the Cochrane review, is about preventing urinary tract infections, and contains nothing at all about leakage.14 That is a different condition, covered in our cranberry piece.

When to see a doctor rather than manage it yourself

Get medical advice promptly for blood in the urine, inability to pass urine or empty your bladder, painful urination or other signs of infection, or needing to pass urine eight or more times a day.8

NICE lists further reasons for specialist referral: persisting bladder or urethral pain, a bladder that can still be felt after voiding, benign pelvic masses, associated bowel incontinence, suspected neurological disease, difficulty passing urine, suspected fistula, or previous continence surgery, pelvic cancer surgery or pelvic radiotherapy.6 Expect a urine dipstick at that first appointment — NICE recommends one for every woman presenting with incontinence — and a bladder diary covering at least three days of your ordinary activities.6

Common questions

Is leaking when I sneeze normal at my age?

Common, certainly — reported prevalence runs as high as 49%, though estimates vary enormously with the population and the definition used.9 But common is not the same as permanent. In trials of supervised pelvic floor training, 56% of women with stress incontinence reported being cured, against 6% of those doing nothing.10 “Treatable” is the more useful word.

Will Kegels fix this, and how long do they take?

They are the treatment with the best evidence, but only in the form the guidelines describe: supervised, at least three months, at least 8 contractions three times a day, and started only after someone has confirmed you can contract the right muscle.6 In that form, Cochrane reports 56% cure versus 6%.10

Is it the same thing as being desperate to go all the time?

No, and mixing them up is why a lot of advice fails. Leaking on effort is stress incontinence; a sudden overwhelming urge is urgency incontinence, and many women have both. NICE requires clinicians to categorise which one you have at the first assessment, because the treatments diverge from that point.6 Cutting caffeine, for instance, is advice aimed at overactive bladder, not at leaking on a sneeze. We separate the two in urgency versus stress incontinence.

Is there a pill for it?

No supplement appears in any of the major guidelines for stress incontinence, and NICE says not to recommend complementary therapies at all for this.6 The one prescription drug in the space, duloxetine, does reduce leaks and improve quality of life, but roughly a third of women report side effects and about one in eight stop taking it — which is why NICE does not put it first or routinely second.136 If you are weighing up the over-the-counter options anyway, our comparison of bladder control supplements for women goes through what each formula can and cannot reasonably claim — and stress leaks are the symptom those ingredients have least to say about.

Weighing up a bladder supplement while you sort out the pelvic floor work? Read our full FemiCore review first — it sets out what is in the formula, what the ingredients have and have not been shown to do, and why we think the honest place for any supplement here is at the edges rather than the centre.

Check current pricing on the official site →

Affiliate link — we may earn a commission at no extra cost to you. We have not used or tested this product.

Bottom line

Leaking when you sneeze is a support problem, not a bladder problem. It usually starts with something that happened decades ago and shows up now because the reserve that was hiding it has run down. The single intervention with high-quality evidence behind it is a supervised pelvic floor programme run properly — three months, eight contractions three times a day, and a check that you are contracting the right muscle. Everything else is a reasonable addition to that, not a substitute for it. And no guideline anywhere recommends a supplement for this, which is worth knowing before you spend money on one.

This article is for information only and is not medical advice. Speak to your GP or a pelvic health physiotherapist about your own symptoms.

More from HerWellReport

Sources

  1. Stress Urinary Incontinence. StatPearls, NCBI Bookshelf. ncbi.nlm.nih.gov/books/NBK539769
  2. The Anatomical Pathogenesis of Stress Urinary Incontinence in Women. Medicina, 2023. mdpi.com/1648-9144/59/1/5
  3. Longitudinal analysis of parity, mode of delivery and urinary incontinence in midlife women (SWAN). Scientific Reports, 2025. nature.com/articles/s41598-025-85603-0
  4. Involuntary Urine Loss in Menopause: A Narrative Review. Journal of Clinical Medicine, 2025. mdpi.com/2077-0383/14/21/7664
  5. Urinary incontinence. NHS. nhs.uk/conditions/urinary-incontinence
  6. Urinary incontinence and pelvic organ prolapse in women: management (NG123). NICE. nice.org.uk/guidance/ng123
  7. Non-neurogenic Female LUTS Guideline: Disease Management. European Association of Urology. uroweb.org
  8. Bladder Control Problems: Symptoms & Causes. NIDDK, National Institutes of Health. niddk.nih.gov
  9. Surgical Treatment of Female Stress Urinary Incontinence Guideline (2017, amended 2023). American Urological Association / SUFU. auanet.org
  10. Pelvic floor muscle training for urinary incontinence in women. Cochrane Database of Systematic Reviews, CD005654. cochrane.org
  11. Mechanical devices for urinary incontinence in women. Cochrane Database of Systematic Reviews, CD001756. cochrane.org
  12. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database of Systematic Reviews, CD001405. cochrane.org
  13. Duloxetine for stress urinary incontinence. Cochrane Database of Systematic Reviews, CD004742. cochrane.org
  14. Cranberries for preventing urinary tract infections. Cochrane Database of Systematic Reviews, CD001321, 2023. cochrane.org